Or Refractory T-cell Lymphomas
📧 Sign up to get email alerts when something new happens for Or Refractory T-cell Lymphomas.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3) [Phase 1, Phase 2]
A Phase 1/2 study evaluating the safety, tolerability, efficacy, and drug levels of BMS-986369 (golcadomide) in participants with relapsed o…